MIMEDX Group Inc.
Company Snapshot
Founded: 2006
Entity Type: Public
Employees: 808
Region: U.S.
Revenue: $418.6 Millions
Revenue Year: 2025
Segment: Regenerative Medicine
Headquarter: Georgia, U.S.
Key Geographics: North America, Europe, Asia-Pacific
Corporate Address: 1775 West Oak Commons Court North East Marietta, Georgia 30062 U.S. Tel. +1-888-543-1917 www.mimedx.com
Company Overview
MIMEDX Group Inc. offers solutions in placental biologics and surgical-healing products, and provides advanced wound care, burn, and surgical-healing services. It operates as a single business unit that develops and distributes placental tissue allografts through patented proprietary processes across various healthcare sectors. It specializes in developing placental-derived biomaterial products for orthopedic, sports, wound care, and surgical applications. In 2024, it expanded its product line to include animal-derived xenografts. It operates in the U.S., while accelerating international market expansion, with a focus on growing its presence in Japan.
Financial Highlights (FY 2025)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
MIMEDX Group Inc. In News
Company's Business Segments
- Regenerative Medicine : The company offers regenerative medicine, specifically focused on the development, manufacturing, and distribution of placental biologics and biomaterials.
Applications/End User Industries
- Advanced Wound Care
- Surgical and Regenerative Medicine